1. Home
  2. CHWY vs ALKS Comparison

CHWY vs ALKS Comparison

Compare CHWY & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Chewy Inc.

CHWY

Chewy Inc.

N/A

Current Price

$21.20

Market Cap

8.8B

ML Signal

N/A

Logo Alkermes plc

ALKS

Alkermes plc

N/A

Current Price

$45.34

Market Cap

7.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CHWY
ALKS
Founded
2010
1987
Country
United States
Ireland
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.8B
7.4B
IPO Year
2019
2012

Fundamental Metrics

Financial Performance
Metric
CHWY
ALKS
Price
$21.20
$45.34
Analyst Decision
Buy
Buy
Analyst Count
26
20
Target Price
$28.64
★ $56.21
AVG Volume (30 Days)
★ 7.0M
1.8M
Earning Date
12-09-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ 0.42
N/A
Revenue
★ $12,601,500,000.00
$1,475,899,000.00
Revenue This Year
$7.32
$23.57
Revenue Next Year
$6.75
$6.58
P/E Ratio
$49.71
★ N/A
Revenue Growth
★ 6.24
N/A
52 Week Low
$17.40
$27.00
52 Week High
$37.34
$55.67

Technical Indicators

Market Signals
Indicator
CHWY
ALKS
Relative Strength Index (RSI) 53.94 60.42
Support Level $19.78 $39.41
Resistance Level $22.31 $47.40
Average True Range (ATR) 0.78 1.47
MACD 0.09 0.58
Stochastic Oscillator 56.77 84.53

Price Performance

Historical Comparison
CHWY
ALKS

About CHWY Chewy Inc.

Founded in 2011, Chewy is a leading e-commerce retailer of pet food, toys, supplies, and medications in North America. The firm offers a comprehensive selection of proprietary and third-party brands, anchored by its highly sticky autoship subscription program, which drives over 83% of its sales. Beyond core retail, Chewy is expanding into high-margin revenue streams, including its retail media network (Chewy Ads), specialized veterinary healthcare software, and brick-and-mortar veterinary clinics to further integrate customers into the Chewy ecosystem.

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Share on Social Networks: